Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.210
-0.100 (-7.63%)
At close: Aug 24, 2026, 4:00 PM EDT
1.270
+0.060 (4.96%)
After-hours: Aug 24, 2026, 7:48 PM EDT

CELZ Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
00.010.010.010.090.09
Revenue Growth
-50.00%-45.45%22.22%-89.84%0.96%-46.65%
Gross Profit
000.010.010.060.04
Operating Income
-6.24-6.14-5.74-5.62-10.24-3.13
Net Income
-6.04-6-5.49-5.29-10.1419.21
Earnings Per Share
-1.95-2.52-3.71-3.76-9.2856.10
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8.847.215.949.9918.410.72
Total Debt
0.010.010.010.010.010.01
Net Cash (Debt)
8.827.195.939.9718.3810.71
Net Cash Growth
35.15%21.39%-40.58%-45.76%71.67%-
Net Cash Per Share
2.853.024.007.0816.8232.97

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.9-5.86-5.3-8.03-7.8-2.22
Free Cash Flow
-5.9-5.86-5.3-8.03-7.8-2.22
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.87%63.43%60.00%60.00%67.84%45.36%
Operating Margin
-208004.40%-102380.23%-52216.92%-62445.91%-11562.50%-3562.17%
Pretax Margin
-201285.83%-99916.80%-49940.74%-58739.71%-11449.26%21892.75%
Profit Margin
-201355.37%-99916.80%-49940.74%-58739.71%-11449.26%21892.76%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----0.73
PS Ratio
2790.851141.59367.17707.9660.55159.35